SamaCare’s Post

During the Clinical Trials Forum 2024 yesterday, our managing director Sabrina Suetens discussed various matters with Caroline Ven, CEO of pharma.be. Clinical trials are a crucial engine of innovation in healthcare. 🤝 In this context, it is important for the #pharma and #medtech sector to collaborate closely. Together, we can target therapies even more precisely, monitor the effects of treatments even more effectively, etc. 💗 In other words, by working together, we can create even greater impact for patients. #ClinicalTrialsForum #clinicaltrials #medicaltechnology #healthinnovation FAGG - Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten

The European Federation of Pharmaceutical Industries and Associations (EFPIA) published the 2023 Patient W.A.I.T. data last month, and the results are consistent with previous years. Consistent in that depending on where rare disease patients live in Europe, their access to new therapeutics varies greatly despite a centralized approval in most of those countries. It also points to the importance of companies having early access programs in place to meet this unmet medical need. There remains much work to do.

Dr. Milind Antani, Lead- Pharma, Healthcare, Medical Device and Digital Healthcare practice, Nishith Desai Associates, shed light on the dynamic changes in diseases, illnesses, and patient profiles driven by various factors in this new age. To tackle these shifts, he emphasized the critical role of the pharmaceutical industry in pioneering new solutions to address and eliminate mutating diseases. #ValueOfInnovation #BharatKeLiye

Digital therapeutics (DTx) have the ability to further revolutionise healthcare, offering innovative digital interventions to prevent, manage, and treat various health conditions. As pharma companies increasingly try to incorporate DTx into their strategies, they face challenges in navigating regulatory uncertainty and slow adoption rates. In our latest article, we explore the complex world of digital therapeutics and present Ipsos' 5-stage framework for developing resilient and scalable DTx businesses. Download the full article to discover key insights and strategies for success in this rapidly evolving industry. https://lnkd.in/eBt6Q5Aj

Explore the forefront of pharmaceutical innovation with Norstella’s May roundup, featuring cutting-edge insights from industry trailblazers and the latest breakthroughs in patient diversity, clinical research, and market analytics. Check out the links below. 👇 Clinical development success rates have steadily been falling over the last decade. This drop is both a concern and inevitable as competition intensifies and the barriers to market entry become higher. Click to read the breakdown on the Norstella blog: https://ow.ly/rsNL50Sjct4 Accelerate your success with Citeline Consulting & Analytics. Using a global lens, Citeline's consultants use deep domain expertise, market-leading insights, and real-world data solutions to optimize your strategy for successful business outcomes. Learn more: https://ow.ly/AcMI50SjcsZ Explore why #radiopharmaceuticals are captivating the industry. In this ebook, Evaluate Ltd discusses the latest science, dealmaking, and commercial opportunities in the landscape, highlighting some of its most intriguing players. Download now: https://ow.ly/nqb850SjcsY Missed Asembia's AXS24 Summit? MMIT (Managed Markets Insight & Technology) has you covered! Check out this blog post for essential insights on personalized medicine, cost management, and maximizing drug lifecycles: https://ow.ly/HU2E50Sjct2 ISPOR Annual 2024 was held in Atlanta, and the Congress did not disappoint. Panalgo's Margaret (Meg) Richards reflects on #ISPORAnnual in this blog, including a discussion on 'whole health' and shifting from patient-centered care to person-centered care. Read it now: https://ow.ly/9KBp50Sjct0 The Dedham Group merges innovative strategies with tailored data solutions to transform businesses. Through clear strategic planning and collaborative partnerships, they boost performance, solidify market presence, and generate substantial value. Learn more: https://ow.ly/IZzi50Sjct3 Follow our brands to stay up with the latest news, insights, and updates. #Pipeline2Patient #FollowNorstella

The trend in parenteral patient therapy has been moving towards the home-care setting for some time as it empowers patient independence. However home administration brings additional requirements when developing a delivery device, and these are constantly evolving. Patient safety is always paramount, but useability is another critical factor, as well as sustainability and connectivity to support patient adherence. The challenge is to design a device to meet as many requirements as possible that can be on the market within 4-8 years. In this presentation we will discuss Gerresheimer’s mission of “innovating for a better life” and how we apply this when developing solutions that respond to the needs of patients, our pharmaceutical industry customers, and the environment, today and into the future. Oliver Haferbeck will be our speaker. Meet our experts and get your ticket: https://lnkd.in/e34qk7FG #innovatingforabetterlife #homecare #drugdeliverydevice #sustainability #connectivity

Strengthening patient engagement to improve health outcomes: today’s insights from Reuters Pharma 2024. At today’s conference we led a number of exciting discussions around patient engagement, including earlier adoption of the patient voice and developing a patient-centric approach to biopharma development to enhance patient outcomes. - There is a need to shift patient-centricity from a process driven by pharmaceutical industry needs to a far more collaborative and shared decision-making process driven by patient, treatment provider, and industry needs. - Patient involvement in clinical trial development is likely to become a regulatory requirement in the future—with the need for greater inclusivity and diversity. - Building meaningful and earlier partnerships with a patient co-creation model throughout the drug development process is likely to lead to better solutions and outcomes, and greater value for patients. Our report is an ideal starting point for context and additional insight: https://lnkd.in/eaQF7XwC We look forward to continuing the conversation with you, through this event and beyond, about developing strategies to drive efficiency across processes and streamline patient access to innovative medicines with the power of AI. #REPharma2024 #MedicalCommunications #HEOR #MarketAccess #WeAreAvalereHealth

Imagine hospitals, clinics, and doctors all teaming up to make healthcare better and more affordable. That's the goal of Integrated Delivery Networks (IDNs). For pharmaceutical companies, joining these networks offers a significant opportunity to expand their market share. By working together and using smart data to understand patient needs, they're making a big difference. Companies like PharmaCorp, BioHeal, and GenPharm have seen the tangible benefits of such alignments. Companies are also embracing new trends like personalized medicine and focusing on treatments that don't require hospital stays. Curious to learn more? Check out the full story here: https://lnkd.in/ewTHfnrb

Hey everyone! I am extremely excited to share with you all the short video about the personalized medication. Personalized medication is a new innovation in healthcare that is revolutionizing the way we treat patients. This innovation tailors the medication to the individual patient's genetic makeup, medical history, and lifestyle, resulting in more effective treatments with fewer side effects. The personalized medication has the potential to transform the pharmaceutical industry and the healthcare sector as a whole by improving patient outcomes and reducing healthcare costs. With this innovation, we can expect to see a shift towards more targeted therapies and personalized care. I have recently uploaded an article on Personalized Medication: A New Dawn in Healthcare and this video is a short summary of the article highlighting the main points. If you want to read the entire article and learn more about the impact of personalized medication, please check out the link below  https://lnkd.in/dp8TtuE4. Let's join the conversation and stay up to date with the latest healthcare innovation. #PersonalizedMedication #HealthcareInnovation #LeadershipinHealthcare #PatientCareMatters #PatientHealthcare #PharmaceuticalIndustryNews #PharmaMarketingStrategies

Absolutely vital insights! 🤔 It's evident from the stats shared that there's a significant gap in addressing the informational needs of healthcare professionals. This data underscores the importance of bridging this divide, not just for HCPs but also for the industry's growth and impact. 🚀 If we have a look at other stats for instance, over 60% of gastroenterologists agree that professional video influences their clinical decisions – a powerful testament to the potential impact of multimedia resources. However, it's concerning that about 50% of them don’t think pharma companies are doing a good job at providing videos for HCPs. 🔍 Similarly, the fact that over 60% of rheumatologists perceive the information provided on pharma websites as mere advertisements for products is a clear indication of the need for non-promotional resources. Despite this perception, there is considerable unmet demand for such resources, which can significantly enhance brand satisfaction and ultimately benefit patient care. 📈 Closing these gaps not only enhances brand satisfaction but also empowers HCPs to make informed clinical decisions. We @Medudy are committed to addressing these challenges head-on and driving meaningful change in the industry! 💪 Felix Stockmar Lucas Amadeus Krauße Eva Klinkenberg Susan Joy Guidi Roberta Müller dr. Luise Mangelsen Sebastian Szur Maren Hötten Julia Fiechtner Anton Müller Therese N. Kai Langohr Viktor Hettich Cagri Elmas Andreas Arntzen Malte von Trotha